Histone hyperacetylation mediates enhanced IL-1β production in LPS/IFN-γ-stimulated macrophages

  • Immunology. 2020 Jun;160(2):183-197. doi: 10.1111/imm.13183.
Zhen Dong   #  1 Ruoshui Li   #  2 Lei Xu   #  1 Kaiyue Xin   #  1 Yamei Xu  1 Haiming Shi  2 Aijun Sun  1  3 Junbo Ge  1  3
Affiliations
  • 1. Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, Shanghai, China.
  • 2. Department of Cardiology, Huashan Hospital, Fudan University, Shanghai, China.
  • 3. Institute of Biomedical Science, Fudan University, Shanghai, China.
  • # Contributed equally.
Abstract

Under the condition of lipopolysaccharide (LPS)/interferon (IFN)-γ activation, macrophage metabolism is converted from Oxidative Phosphorylation to glycolysis. In the present work, we analysed whether glycolysis could affect interleukin (IL)-1β expression through altering histone acetylation levels in mouse bone marrow-derived macrophages. Immunocytochemistry and Western blot analysis are used to characterize histone acetylation in macrophages stimulated by LPS/IFN-γ. Real-time polymerase chain reaction and enzyme-linked immunosorbent assay were used to determine IL-1β production. The metabolism of macrophages was monitored in real-time by the Seahorse test. Our results showed that glycolytic metabolism could enhance histone acetylation and promote IL-1β production in LPS/IFN-γ-activated macrophages. Moreover, increased production of IL-1β by glycolysis was mediated through enhanced H3K9 acetylation. Importantly, it was found that a high dose of histone deacetylase inhibitor could also significantly increase the expression of IL-1β in the absence of glycolytic metabolism. In conclusion, this study demonstrates that glycolytic metabolism could regulate IL-1β expression by increasing histone acetylation levels in LPS/IFN-γ-stimulated macrophages.

Keywords
HDAC inhibitor; IL-1β; glycolysis; histone hyperacetylation; macrophage.
Products